"Diabetes Complications" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE.
| Descriptor ID |
D048909
|
| MeSH Number(s) |
C19.246.099
|
| Concept/Terms |
Diabetes Complications- Diabetes Complications
- Diabetes Complication
- Diabetes-Related Complications
- Diabetes Related Complications
- Diabetes-Related Complication
- Diabetic Complications
- Diabetic Complication
- Complications of Diabetes Mellitus
- Diabetes Mellitus Complication
- Diabetes Mellitus Complications
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Complications".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Complications".
This graph shows the total number of publications written about "Diabetes Complications" by people in this website by year, and whether "Diabetes Complications" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Complications" by people in Profiles.
-
Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications. Theranostics. 2025; 15(8):3551-3570.
-
Effect of inadequate care on diabetes complications and healthcare resource utilization during management of type 2 diabetes in the United States. Postgrad Med. 2022 Jun; 134(5):494-506.
-
Novel N-pyrimidin-4-yl-3-amino-pyrrolo [3, 4-C] pyrazole derivatives as PKC kinase inhibitors: a patent evaluation of US2015099743 (A1). Expert Opin Ther Pat. 2016; 26(4):523-8.